Related Experiment Video
Updated: Sep 23, 2025

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
Published on: October 11, 2024
Structural and Functional Support by Left Atrial Appendage Transplant to the Left Ventricle after a Myocardial
Jussi V Leinonen1, Päivi Leinikka1, Miikka Tarkia1
1Department of Pharmacology, Faculty of Medicine, University of Helsinki, Haartmaninkatu 8, P.O. Box 63, 00014 Helsinki, Finland.
Left atrial appendage (LAA) transplantation shows promise for treating myocardial infarction. This approach combines regenerative cell therapy with physical support to improve heart function and reduce adverse remodeling.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Tissue Engineering
Background:
- The adult left atrial appendage (LAA) contains cardiac and myeloid progenitor cells.
- Myeloid progenitor cells in the LAA secrete pro-regenerative factors.
- Cardiac constructs can mitigate heart remodeling through physical support.
Purpose of the Study:
- To investigate the potential of LAA transplantation as a regenerative therapy for myocardial infarction (MI).
- To evaluate the combined effects of cell therapy and physical support from LAA patches in a mouse MI model.
Main Methods:
- Adult mouse LAAs were transplanted into recipient mice undergoing simultaneous MI.
- A decellularized LAA patch served as a control group.
- Cellular infiltration, phenotypes, and cardiac function were assessed post-transplantation.
Main Results:
- LAA patches integrated with the ventricular wall and showed cell migration into the MI area.
- Transplanted cells exhibited phenotypes of myeloid (F4/80+) and cardiac (troponin C+) cells.
- LAA patch treatment significantly improved cardiac performance and inhibited hypertrophic remodeling compared to controls.
Conclusions:
- LAA transplantation is a potential therapeutic strategy for myocardial infarction.
- This method offers a dual benefit of cell-based regeneration and physical patch support.
- LAA patches effectively reduce deleterious cardiac remodeling and improve heart function post-MI.
More Related Videos
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
08:49Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Cardiac Catheterization III: Left Heart Catheterization
Chambers of the Heart
Deoxygenated blood from the body is received in the right...
Cardiomyopathy II: Dilated Cardiomyopathy